165 related articles for article (PubMed ID: 26694173)
1. AKT and JNK Signaling Pathways Increase the Metastatic Potential of Colorectal Cancer Cells by Altering Transgelin Expression.
Zhou H; Zhang Y; Chen Q; Lin Y
Dig Dis Sci; 2016 Apr; 61(4):1091-7. PubMed ID: 26694173
[TBL] [Abstract][Full Text] [Related]
2. Apigenin up-regulates transgelin and inhibits invasion and migration of colorectal cancer through decreased phosphorylation of AKT.
Chunhua L; Donglan L; Xiuqiong F; Lihua Z; Qin F; Yawei L; Liang Z; Ge W; Linlin J; Ping Z; Kun L; Xuegang S
J Nutr Biochem; 2013 Oct; 24(10):1766-75. PubMed ID: 23773626
[TBL] [Abstract][Full Text] [Related]
3. Transgelin increases metastatic potential of colorectal cancer cells in vivo and alters expression of genes involved in cell motility.
Zhou HM; Fang YY; Weinberger PM; Ding LL; Cowell JK; Hudson FZ; Ren M; Lee JR; Chen QK; Su H; Dynan WS; Lin Y
BMC Cancer; 2016 Feb; 16():55. PubMed ID: 26847345
[TBL] [Abstract][Full Text] [Related]
4. Association of the actin-binding protein transgelin with lymph node metastasis in human colorectal cancer.
Lin Y; Buckhaults PJ; Lee JR; Xiong H; Farrell C; Podolsky RH; Schade RR; Dynan WS
Neoplasia; 2009 Sep; 11(9):864-73. PubMed ID: 19724680
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of microRNA-302a inhibited the proliferation and invasion of colorectal cancer cells by regulation of the MAPK and PI3K/Akt signaling pathways.
Wei ZJ; Tao ML; Zhang W; Han GD; Zhu ZC; Miao ZG; Li JY; Qiao ZB
Int J Clin Exp Pathol; 2015; 8(5):4481-91. PubMed ID: 26191138
[TBL] [Abstract][Full Text] [Related]
6. A rat-to-human search for proteomic alterations reveals transgelin as a biomarker relevant to colorectal carcinogenesis and liver metastasis.
Peng J; Zhang Q; Ma Y; Wang Y; Huang L; Zhang P; Chen J; Qin H
Electrophoresis; 2009 Sep; 30(17):2976-2987. PubMed ID: 19711377
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2.
Liang L; Li X; Zhang X; Lv Z; He G; Zhao W; Ren X; Li Y; Bian X; Liao W; Liu W; Yang G; Ding Y
Gastroenterology; 2013 Mar; 144(3):624-635.e4. PubMed ID: 23201162
[TBL] [Abstract][Full Text] [Related]
8. Transgelin is a poor prognostic factor associated with advanced colorectal cancer (CRC) stage promoting tumor growth and migration in a TGFβ-dependent manner.
Elsafadi M; Manikandan M; Almalki S; Mahmood A; Shinwari T; Vishnubalaji R; Mobarak M; Alfayez M; Aldahmash A; Kassem M; Alajez NM
Cell Death Dis; 2020 May; 11(5):341. PubMed ID: 32393769
[TBL] [Abstract][Full Text] [Related]
9. Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells.
Brand S; Olszak T; Beigel F; Diebold J; Otte JM; Eichhorst ST; Göke B; Dambacher J
J Cell Biochem; 2006 Mar; 97(4):709-23. PubMed ID: 16215992
[TBL] [Abstract][Full Text] [Related]
10. Expression of the actin-associated protein transgelin (SM22) is decreased in prostate cancer.
Prasad PD; Stanton JA; Assinder SJ
Cell Tissue Res; 2010 Feb; 339(2):337-47. PubMed ID: 20012321
[TBL] [Abstract][Full Text] [Related]
11. Salvianolic acid A reverses paclitaxel resistance in human breast cancer MCF-7 cells via targeting the expression of transgelin 2 and attenuating PI3 K/Akt pathway.
Cai J; Chen S; Zhang W; Zheng X; Hu S; Pang C; Lu J; Xing J; Dong Y
Phytomedicine; 2014 Oct; 21(12):1725-32. PubMed ID: 25442283
[TBL] [Abstract][Full Text] [Related]
12. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
[TBL] [Abstract][Full Text] [Related]
13. Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer.
Ding C; Luo J; Li L; Li S; Yang L; Pan H; Liu Q; Qin H; Chen C; Feng J
J Exp Clin Cancer Res; 2016 Jan; 35():5. PubMed ID: 26754532
[TBL] [Abstract][Full Text] [Related]
14. Identification of Novel Biomarkers for Metastatic Colorectal Cancer Using Angiogenesis-Antibody Array and Intracellular Signaling Array.
Chung S; Dwabe S; Elshimali Y; Sukhija H; Aroh C; Vadgama JV
PLoS One; 2015; 10(8):e0134948. PubMed ID: 26258407
[TBL] [Abstract][Full Text] [Related]
15. Nicotine enhances invasion and metastasis of human colorectal cancer cells through the nicotinic acetylcholine receptor downstream p38 MAPK signaling pathway.
Xiang T; Fei R; Wang Z; Shen Z; Qian J; Chen W
Oncol Rep; 2016 Jan; 35(1):205-10. PubMed ID: 26530054
[TBL] [Abstract][Full Text] [Related]
16. Harmine induces cell cycle arrest and mitochondrial pathway-mediated cellular apoptosis in SW620 cells via inhibition of the Akt and ERK signaling pathways.
Liu J; Li Q; Liu Z; Lin L; Zhang X; Cao M; Jiang J
Oncol Rep; 2016 Jun; 35(6):3363-70. PubMed ID: 27004568
[TBL] [Abstract][Full Text] [Related]
17. [Expression of transgelin-2 and clinical significance in colorectal cancer].
Zhuo HQ; Zhang YB; Zhang H; Guo P; Lü Y; Dong LY; Jiang KW; Ye YJ; Wang S
Zhonghua Wai Ke Za Zhi; 2012 Jun; 50(6):551-4. PubMed ID: 22943952
[TBL] [Abstract][Full Text] [Related]
18. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of RhoGDI2 correlates with tumor progression and poor prognosis in colorectal carcinoma.
Li X; Wang J; Zhang X; Zeng Y; Liang L; Ding Y
Ann Surg Oncol; 2012 Jan; 19(1):145-53. PubMed ID: 21861235
[TBL] [Abstract][Full Text] [Related]
20. Extracellular translationally controlled tumor protein promotes colorectal cancer invasion and metastasis through Cdc42/JNK/ MMP9 signaling.
Xiao B; Chen D; Luo S; Hao W; Jing F; Liu T; Wang S; Geng Y; Li L; Xu W; Zhang Y; Liao X; Zuo D; Wu Y; Li M; Ma Q
Oncotarget; 2016 Aug; 7(31):50057-50073. PubMed ID: 27367023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
